134 related articles for article (PubMed ID: 19406055)
1. [Visualisation of prostate cancer liver metastases on a 99mTc-MDP bone scan].
Loaiza Góngora JL; Hervás Benito I; Bello Arques P; Vercher Conejero JL; Mateo Navarro A
Rev Esp Med Nucl; 2009; 28(2):80. PubMed ID: 19406055
[No Abstract] [Full Text] [Related]
2. Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen.
Norris S; Halkar R; Galt J; Petros J; Keller J
Clin Nucl Med; 1999 Nov; 24(11):905-7. PubMed ID: 10551485
[No Abstract] [Full Text] [Related]
3. Case report: accumulation of 99mTc-hydroxymethylene diphosphonate by liver metastases of prostatic adenocarcinoma.
Mannion RA; Johnson M
Clin Radiol; 1993 Mar; 47(3):209-10. PubMed ID: 8472488
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
5. PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?
Rowe SP; Mana-Ay M; Javadi MS; Szabo Z; Leal JP; Pomper MG; Pienta KJ; Ross AE; Gorin MA
Clin Genitourin Cancer; 2016 Feb; 14(1):e115-8. PubMed ID: 26603549
[No Abstract] [Full Text] [Related]
6. Tc-99m MDP uptake in liver metastases from adenocarcinoma of the duodenum.
Erdogan S; Barutca S; Yurekli Y
Clin Nucl Med; 2004 Feb; 29(2):125. PubMed ID: 14734917
[No Abstract] [Full Text] [Related]
7. [Benign myocardial uptake of 99mTc-HMDP in prostate carcinoma: based on three cases].
Poblete García VM; Rodado Marina S; García Vicente A; Soriano Castrejón A
Rev Esp Med Nucl; 2003; 22(1):35-9. PubMed ID: 12550032
[TBL] [Abstract][Full Text] [Related]
8. Super bone scan: bone metastases of prostate cancer.
Shikino K; Ikusaka M; Hirota Y; Sato E
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25228679
[No Abstract] [Full Text] [Related]
9. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
Haseman MK
Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
[TBL] [Abstract][Full Text] [Related]
10. [Solitary hypermetabolic bone focus in the initial extension study of a prostate carcinoma].
Sampol Bas C; Peña Viloria C; Giménez García M
Rev Esp Med Nucl; 2005; 24(6):414-7. PubMed ID: 16324519
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
Garcia JR; Simo M; Perez G; Soler M; Lopez S; Setoain X; Lomeña F
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
[No Abstract] [Full Text] [Related]
12. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
Yuksel M; Cermik TF; Kaya M; Salan A; Ustun F; Salihoglu YS; Yigitbasi ON; Berkarda S
Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863
[No Abstract] [Full Text] [Related]
13. Liver and lymph node metastases of prostate cancer visualized on post-therapy imaging after treatment with 188Re-HEDP.
Khalaf F; Dogan AS; Haslerud T; Sabet A; Biersack HJ; Ezziddin S
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):58-9. PubMed ID: 23727275
[No Abstract] [Full Text] [Related]
14. Solitary Scapular Metastasis as the First Presentation of Prostate Adenocarcinoma Identified on 99mTc-MDP SPECT/CT.
Liu W; Zheng XZ; Dong ZQ; Huang JM; Xie P
Clin Nucl Med; 2023 Jan; 48(1):92-94. PubMed ID: 36469070
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
Shimizu N; Masuda H; Yamanaka H; Oriuchi N; Inoue T; Endo K
J Urol; 1999 Feb; 161(2):608-9. PubMed ID: 9915462
[No Abstract] [Full Text] [Related]
16. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents.
Bushnell DL; Madsen M; Kahn D; Nathan M; Williams RD
Nucl Med Commun; 1999 Oct; 20(10):875-81. PubMed ID: 10528290
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic dilemma of urinary leak vs. perirenal abscess on skeletal scintigraphy: The added value of SPECT/CT and renal scintigraphy.
Jain TK; Basher RK; Mittal BR; Bhatia A; Singh SK; Bhattacharya A
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):48-50. PubMed ID: 26139031
[No Abstract] [Full Text] [Related]
18. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
19. PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study.
Fellner M; Baum RP; Kubícek V; Hermann P; Lukes I; Prasad V; Rösch F
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):834. PubMed ID: 20069291
[No Abstract] [Full Text] [Related]
20. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
